Cara Therapeutics Inc (CARA) is around the bottom of the Biotechnology industry according to InvestorsObserver. CARA received an overall rating of 34, which means that it scores higher than 34 percent of all stocks. Cara Therapeutics Inc also achieved a score of 26 in the Biotechnology industry, putting it above 26 percent of Biotechnology stocks. Biotechnology is ranked 54 out of the 148 industries.
CARA has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on CARA!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 34 means the stock is more attractive than 34 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Cara Therapeutics Inc Stock Today?
Cara Therapeutics Inc (CARA) stock is trading at $0.94 as of 12:49 PM on Tuesday, Nov 28, an increase of $0.01, or 0.92% from the previous closing price of $0.93. The stock has traded between $0.91 and $0.96 so far today. Volume today is less active than usual. So far 114,371 shares have traded compared to average volume of 482,243 shares.
Click Here to get the full Stock Report for Cara Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
